Login
$PDSB
$1.52 +$0.22 (16.92%) Close

Insider Transactions

What PDS Biotechnology Corp's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 0
Total trades 0 0

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Glover Steve C Director Feb 28 Open-market buy · P +15,061 $1.66 +$25K 78,851
Freitag Gregory Gene Director Feb 28 Open-market buy · P +15,060 $1.66 +$25K 61,213
Bedu-addo Frank President/CEO Dec 02 Withheld — tax / exercise cost · F −175,184 $9.78 −$1.71M 690,866
Bedu-addo Frank President/CEO Dec 02 Exercise / conversion · M +219,535 $6.57 +$1.44M 866,050
Hill Mathew C Chief Financial Officer Dec 13 Open-market buy · P +100 $9.00 +$900 4,075
Hill Mathew C Chief Financial Officer Dec 13 Open-market buy · P +100 $9.00 +$900 3,975
Hill Mathew C Chief Financial Officer Dec 13 Open-market buy · P +400 $8.90 +$3.56K 3,875
Hill Mathew C Chief Financial Officer Dec 13 Open-market buy · P +2,500 $9.00 +$22.5K 3,475
Bloomquist DeLyle W Insider Jun 16 Open-market buy · P +10,000 $9.88 +$98.8K 193,888
Bloomquist DeLyle W Insider Jun 16 Exercise / conversion · M +2,970 $5.99 +$17.8K 183,888
Ali-Jackson Kamil Director Jun 15 Open-market buy · P +11,764 $8.50 +$100K 11,764
Van Voorhees Seth Chief Financial Officer Jun 15 Open-market buy · P +17,647 $8.50 +$150K 17,647
Glover Steve C Director Jun 15 Open-market buy · P +5,882 $8.50 +$50K 63,790
Bedu-addo Frank President/CEO Jun 15 Withheld — tax / exercise cost · F −27,166 $12.86 −$349K 646,515
Bedu-addo Frank President/CEO Jun 15 Exercise / conversion · M +53,174 $6.57 +$349K 673,681
Freitag Gregory Gene Director Jun 15 Open-market buy · P +5,882 $8.50 +$50K 46,153
Saik Andrew Chief Financial Officer Feb 14 Grant / award · A +38,400 $1.30 +$49.9K 42,549
Glover Steve C Director Feb 14 Grant / award · A +38,400 $1.30 +$49.9K 57,908
Sykes Richard Director Feb 14 Grant / award · A +384,615 $1.30 +$500K 445,108
Freitag Gregory Gene Director Feb 14 Grant / award · A +38,400 $1.30 +$49.9K 40,271

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support